| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3166d2820b5872ab84d235e5fae1d45 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate |
2015-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5c4c2624b47ef04952d4978b0ee6f3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1621aa8516677dd22ccc1b9e292b2b27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_654b5678e93ef0c10e41ffcb0820651a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a25d4159d3adcc37aebafc9104f343a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d7d4d656b2ace13b766abb13e0259a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed05af3eda65a5d8d3fa9afef5cb106b |
| publicationDate |
2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2015268725-B2 |
| titleOfInvention |
Treatment for lipodystrophy |
| abstract |
TREATMENT FOR LIPODYSTROPHY The present invention provides a therapeutic compound of formula (I) and their 5 pharmaceutically acceptable salts for the prevention and treatment of lipodystrophy caused because of HIV infection or combination therapy of HIV-1 protease inhibitors (PIs) and/or reverse transcriptase inhibitors (nRTIs) by neutralizing lipohypertrophy, lipoatrophy and metabolic abnormalities in HIV patient. |
| priorityDate |
2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |